Hemolytic Uremic Syndrome Causes and Characteristics

Typical HUS Causes and Transmission

The Centers for Disease Control and Prevention recommends that Shiga toxin-producing Escherichia coli (STEC), particularly E. coli O157:H7, is the primary cause of Hemolytic Uremic Syndrome (HUS), with approximately 8% of infected persons developing HUS 1, 2, 3
Non-O157 STEC strains, such as serogroups O26, O45, O103, O111, O121, and O145, also cause HUS, though less frequently 1, 3
The World Health Organization notes that Shigella dysenteriae type 1 can produce Shiga toxin and cause HUS, especially in travelers to endemic areas 4
STEC transmission occurs through consumption of undercooked ground beef, unpasteurized juice, raw milk, and raw produce, as well as ingestion of contaminated water, direct contact with animals or their environment, and person-to-person transmission, particularly in child-care settings 1, 2, 3
The infectious dose is remarkably low, with less than 100 organisms required for O157 and O111 strains to cause infection 1, 2

Atypical HUS represents approximately 5-10% of all HUS cases and is caused by genetic mutations in complement regulatory proteins or autoantibodies against complement regulatory proteins 5, 6
The American Society of Nephrology notes that atypical HUS has a relapsing course, with more than 50% of patients progressing to chronic renal dysfunction and 10% mortality 6

The Centers for Disease Control and Prevention recommends that children under 5 years have the highest incidence of STEC infection and greatest risk for HUS progression 1, 2, 3
The American Academy of Pediatrics notes that young children represent the primary demographic for typical HUS, as it is the most common cause of acute renal failure requiring dialysis in this age group 6
Antibiotic therapy in STEC infections may worsen outcomes and potentially increase HUS risk, making prompt diagnosis essential to avoid inappropriate treatment 1, 2, 3
If platelet count obtained within 7 days after gastrointestinal illness onset is not below 150,000/mm³, consider alternative diagnoses 6

The National Institute of Diabetes and Digestive and Kidney Diseases notes that Systemic Lupus Erythematosus and lupus nephritis with monoclonal immunoglobulins acting as autoantibodies against complement regulatory proteins can produce similar thrombotic microangiopathy 5
Antiphospholipid syndrome causing antiphospholipid syndrome nephropathy through inhibition of prostacyclin formation or protein C activation can also produce HUS-like syndromes 5
Chronic hemolytic anemias, such as sickle cell disease, thalassemia, and hereditary spherocytosis, resulting in TMA due to high nitric oxide consumption can also cause HUS-like syndromes 5

The American Academy of Pediatrics notes that patients with HUS typically develop diarrhea, which precedes HUS by 4-5 days, with bloody diarrhea occurring in approximately 60% of cases 7
The timing of diarrhea onset helps distinguish etiologies: STEC-HUS typically appears 4-5 days after diarrhea onset, while simultaneous onset of diarrhea and HUS suggests atypical HUS 7

Genetic mutations in complement regulatory proteins, such as CFH, CFI, CD46, C3, CFB, THBD, and CFHR1-5, occur in approximately 60% of atypical HUS cases, leading to excessive complement activation and formation of the membrane attack complex (C5b-9) on endothelial cells 7
Antiphospholipid syndrome can cause HUS-like syndromes by inhibiting prostacyclin formation and protein C activation, according to the American Heart Association 8

When atypical HUS presents in the first year of life, mutations in complement-unrelated genes, such as DGKE and WT1, should be considered, as noted by the European Society of Pediatric Nephrology 7
Methylmalonic acidemia with homocystinuria cblC type (MMACHC) represents an ultra-rare metabolism-associated HUS caused by cobalamin deficiency, as reported by the Society for Pediatric Research 7

Administering IV fluids during the diarrhea phase reduces the risk of oligoanuric renal failure in children who subsequently develop HUS, as recommended by the American Academy of Pediatrics 9, 10
Dehydration at admission is associated with increased need for dialysis in post-diarrheal HUS, highlighting the importance of early hydration assessment and management 9, 10

When anemia plus thrombocytopenia presents in the emergency setting, immediately obtain LDH, Direct Coombs test, and peripheral blood smear for schistocytes to aid in diagnosis 11, 12, 13
The diagnostic triad for HUS consists of platelet consumption, microangiopathic hemolysis, and renal involvement, as outlined by the International Society of Nephrology 11

When clinical history suggests Shiga toxin-producing organism, apply diagnostic approaches that detect Shiga toxin (or genes encoding them) and distinguish E. coli O157:H7 from other STEC in stool, as recommended by the Centers for Disease Control and Prevention 9, 10
Test for both STEC O157 culture AND Shiga toxin/genes, and consider distinguishing between Shiga toxin 1 and Shiga toxin 2 (stx2 is more potent and associated with higher HUS risk) 9, 10

For diagnosed or suspected STEC infection, perform frequent monitoring to detect early HUS manifestations, including daily hemoglobin and platelet counts, and examine peripheral blood smear for red blood cell fragmentation 12, 13

Neurological involvement occurs in 10-20% of patients and is the first cause of death, highlighting the importance of neurological monitoring and consultation 11, 13, 14
Early recognition, appropriate treatment, and multidisciplinary approach are critical to reduce risk of irreversible organ damage or death, as emphasized by the American College of Critical Care Medicine 14

Regular follow-up is recommended until laboratory and clinical parameters normalize, as suggested by the National Institute of Diabetes and Digestive and Kidney Diseases 15